Editor’s note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard Law School on Monday, January 23rd, 2017. The conference brought together leading experts to review major developments in health
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/03/10/manufacturers-of-biosimilar-drugs-sit-out-the-patent-dance/
Posted
Mar 10 2017, 07:12 AM
by
Health Affairs BlogHealth Affairs Blog